Prescription drug · NDA
dopamine hydrochloride in dextrose NDC 51662-1681
Dopamine hydrochloride 1.6 mg/mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1681-3 | 5166216810351662168103 | 12 POUCH in 1 CASE (51662-1681-3) / 1 BAG in 1 POUCH (51662-1681-2) / 250 mL in 1 BAG (51662-1681-1)Marketed from Nov 5, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- dopamine hydrochloride in dextrose
- Generic name (nonproprietary)
- dopamine hydrochloride in dextrose
- Active ingredients
- Dopamine hydrochloride — 1.6 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018826
- Marketing start
- Listing expires
- Other FDA classes
- Catecholamines (Chemical structure)
- Identifiers
- Product ID 51662-1681_513f7cfb-091b-f8c0-e063-6394a90a0fe2SPL ID 513f7cfb-091b-f8c0-e063-6394a90a0fe2SPL set ID 513f7cfb-091a-f8c0-e063-6394a90a0fe2RxCUI 1743877UNII 7L3E358N9L
- Pharmacologic class
- Catecholamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662168103followed by a unit qualifier and the quantityPackage 51662-1681-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dopamine Hydrochloride in Dextrose Injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output.
Excerpt only. Read the full label for complete information.
About NDC 51662-1681
- What is NDC 51662-1681?
- 51662-1681 is the product NDC for dopamine hydrochloride in dextrose, Dopamine hydrochloride 1.6 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- dopamine hydrochloride in dextrose.
- What is the active ingredient?
- Dopamine hydrochloride.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for dopamine hydrochloride in dextrose?
- 3 other product NDCs are listed under this name. See all dopamine hydrochloride in dextrose NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other dopamine hydrochloride in dextrose products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 1.6 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-0042 | 00409-0042-12 |
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 3.2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1858 | 00409-1858-12 |
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 1.6 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-7809 | 00409-7809-24 |
Other NDCs under NDA 018826
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dopamine Hydrochloride | Dopamine hydrochloride 1.6 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1316 |
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 1.6 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-0042 |
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 3.2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1858 |
| Dopamine Hydrochloride in Dextrose | Dopamine hydrochloride 1.6 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-7809 |